Europeiska unionen - svenska - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artrit, reumatoid - immunsuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 10 mg - oxikodonhydroklorid 10 mg aktiv substans; stearylalkohol hjälpämne; laktosmonohydrat hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 15 mg - oxikodonhydroklorid 15 mg aktiv substans; stearylalkohol hjälpämne; laktosmonohydrat hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 20 mg - laktosmonohydrat hjälpämne; oxikodonhydroklorid 20 mg aktiv substans; stearylalkohol hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 30 mg - stearylalkohol hjälpämne; oxikodonhydroklorid 30 mg aktiv substans; laktosmonohydrat hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 40 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; oxikodonhydroklorid 40 mg aktiv substans - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 5 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; oxikodonhydroklorid 5 mg aktiv substans - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 60 mg - stearylalkohol hjälpämne; oxikodonhydroklorid 60 mg aktiv substans; laktosmonohydrat hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - oxikodonhydroklorid - depottablett - 80 mg - stearylalkohol hjälpämne; oxikodonhydroklorid 80 mg aktiv substans; laktosmonohydrat hjälpämne - oxikodon

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

meda ab - dl-metionin; fenylalanin; histidin; isoleucin; leucin; lysinacetat; treonin; tryptofan; tyrosin; valin - granulat i dospåse - isoleucin 300 mg aktiv substans; valin 675 mg aktiv substans; histidin 225 mg aktiv substans; aspartam hjälpämne; sackaros hjälpämne; mannitol hjälpämne; lysinacetat 480 mg aktiv substans; treonin 325 mg aktiv substans; tryptofan 125 mg aktiv substans; dl-metionin 450 mg aktiv substans; tyrosin 375 mg aktiv substans; leucin 450 mg aktiv substans; fenylalanin 350 mg aktiv substans - inkl kombinationer med polypeptider